Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Papivax

2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of immunotherapies. The company provides therapies for the prevention of human papillomavirus (HPV).

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare
Primary Office
  • 645 Baltimore Annapolis
  • Severna Park, MD 21146
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Papivax’s full profile, request a free trial.

Papivax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 01-Jun-2014 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Papivax Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0

Papivax Executive Team (1)

Name Title Board
Seat
Contact
Info
Yung-Nien Chang Ph.D Chief Scientific Officer